Related Experiment Video
Updated: Jun 5, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
The molecular biology of prostate cancer morbidity and mortality: Accelerated death from ejaculate poisoning?
1From the Johns Hopkins Oncology Center and the James Buchanan Brady Urological Institute, NIH Special Program of Research Excellence in Prostate Cancer, The Johns Hopkins Hospital, Baltimore, Maryland, USA.
Abstract:
The molecular biology of host-tumor interactions unique to human prostate cancer that cause patient morbidity are poorly understood despite the prevalence of this neoplasm. Little is known fundamentally about prostate-specific exocrine gene products secreted by metastatic prostate carcinoma cells at metastatic sites that cause diffuse bone pain, immunosuppression, anemia, cachexia, and other clinical signs of advanced prostate cancer. Growing evidence supports the presence of androgen-regulated exocrine gene products as independent mediators of prostate cancer morbidity. The experimental and clinical implications of a hypothesis that prostate-specific exocrine genes cause patient morbidity are discussed.
Insights
Prostate cancer
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Prostate cancer's molecular biology and host-tumor interactions causing morbidity remain poorly understood.
- The role of prostate-specific exocrine gene products in advanced prostate cancer symptoms like bone pain and cachexia is unclear.
Purpose of the Study:
- To explore the poorly understood molecular mechanisms of host-tumor interactions in prostate cancer.
- To investigate the role of prostate-specific exocrine gene products in mediating cancer morbidity.
Main Methods:
- Literature review and hypothesis discussion.
- Analysis of existing evidence on androgen-regulated exocrine gene products.
Main Results:
- Growing evidence suggests androgen-regulated exocrine gene products may independently drive prostate cancer morbidity.
- Prostate-specific exocrine genes are implicated in symptoms of advanced disease.
Conclusions:
- Prostate-specific exocrine genes are hypothesized to be key mediators of prostate cancer patient morbidity.
- Understanding these genes has significant experimental and clinical implications for managing advanced prostate cancer.
More Related Videos
Related Concept Videos
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Sperm Transport
The maturation phase occurs in the epididymis, where sperm...
Spermatogenesis
Male Sexual Response: Erection & Ejaculation
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...

